USA Proton Therapy Market to exceed USD 15 Billion by 2021, with CAGR of 6.04 Percent
USA Proton Therapy Market News Analyst View: USA Proton Therapy Market to exceed USD 15 Billion by 2021, with CAGR of 6.04 Percent For More Information: http://www.renub.com/usa-proton-therapy-market-to-exceed-usd-15-billion-by-2021-withcagr-of-6-04-percent-23-nd.php Download full Report: http://www.renub.com/united-states-proton-therapy-market-and-forecast-reimbursementpolicy-patients-treated-at-proton-therapy-centers-1045-p.php A new report by Renub Research, titled “United States Proton Therapy Market & Forecast, Reimbursement Policy and Patients Treated at Proton Therapy Centers” provides comprehensive insight of United States Proton Therapy Market. Proton therapy evolves as a prime radiation treatment modality. The compliance of proton therapy into clinical practice for more than 2 decades in United States makes it one of the advanced radio therapy tool to fight deadly cancerous tumor like Brain cancer, Eye cancer, Prostate cancer, Colon and rectal cancer, Breast cancer etc. In recent times, many research institutes and hospitals are investing in proton therapy to make proton therapy technology more affordable and accessible to patients. Rising cancer prevalence and increasing waiting list of high risk cancer patients shows high credential and acceptance of proton therapy in United States.
Proton Therapy Market in United States The potential demand of proton therapy market in United States for the year 2021 is expected to be higher than USD 15 Billion, growing with a CAGR of 6.04 percent. USA holds the major market share in Global Proton Therapy Market.
Proton Therapy is far better than Standard Therapy
© Renub Research LLP
Page 1 of 2